IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
IOL Chemicals & Pharmaceuticals submitted its Annual Secretarial Compliance Report for FY 2025-26, examined by M/s B.K. Gupta & Associates. The report covers compliance with SEBI regulations including LODR, SAST, PIT, and other applicable rules. The company maintained compliance across all major areas including secretarial standards, website disclosures, director qualifications, related party transactions, and insider trading norms. Two minor deviations were noted: a one-day delay in filing Q3 shareholding pattern with BSE (for quarter ended 31.12.2025), resulting in a fine of Rs. 2,000 plus GST which was paid; and a prior-year issue regarding vacancy in women independent director position which was rectified in October 2024 with the penalty duly paid. All other compliance requirements were satisfied.
Minor regulatory penalty of Rs. 2,360 for a one-day filing delay indicates isolated administrative lapse rather than systemic governance issues. The company has remediated past issues and demonstrated overall compliance culture, which should not materially impact investor sentiment.